SEARCH

SEARCH BY CITATION

References

  • Ageno, W., Steidl, L., Ultori, C., Dentali, F., Marchesi, C., Mera, V., Squizzato, A. & Venco, A. (2003) The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. Blood Coagulation and Fibrinolysis, 14, 1114.
  • Ansell, J.E. (2003) The perioperative management of warfarin therapy. Archives of Internal Medicine, 163, 881883.
  • British Committee for Standards in Haematology (1998) Guidelines on oral anticoagulation: third edition. British Journal of Haematology, 101, 374387.
  • British Committee for Standards in Haematology (2001) Investigation and management of heritable thrombophilia. British Journal of Haematology, 114, 512528.
  • Crowther, M.A., Ginsberg, J.B., Kearon, C., Harrison, L., Johnson, J., Massicotte, M.P. & Hirsh, J. (1999) A randomized trial comparing 5-mg and 10-mg warfarin loading doses. Archives of Internal Medicine, 159, 4648.
  • Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. & Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. New England Journal of Medicine, 349, 11331138.
  • Department of Health (2004) Building a Safer NHS for Patients. Improving Medication Safety. A Report by the Chief Pharmaceutical Officer. Department of Health, London. WWW document. URL. http://www.dh.gov.uk/PublicationsAndStatistics.
  • Dunn, A. & Turpie, A. (2003) Perioperative management of patients receiving oral anticoagulants. Archives of Internal Medicine, 163, 901908.
  • Evans, G., Luddington, R. & Baglin, T. (2001) Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. British Journal of Haematology, 115, 9981001.
  • Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D'Angelo, A., Tognoni, G. & Barbui, T. (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848853.
  • Gallagher, M.M., Hennessy, B.J., Edvardsson, N., Hart, C.M., Shannon, M.S., Obel, O.A., Al-Saady, N.M. & Camm, A.J. (2002) Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. Journal of the American College of Cardiology, 40, 926933.
  • Gedge, J., Orme, S., Hampton, K.K., Channer, K.S. & Hendra, T.J. (2000) A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age and Ageing, 29, 3134.
  • Hall, C., Richards, S. & Hillmen, P. (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood, 102, 35873591.
  • Harrison, L., Johnston, M., Massicotte, M.P., Crowther, M., Moffat, K. & Hirsh, J. (1997) Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Annals of Internal Medicine, 126, 133136.
  • van der Heijden, J., Hutten, B., Büller, H. & Prins, M. (2001) Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. The Cochrane Database of Systematic Reviews, doi: 10.1002/14651858.CD002001.
  • Janes, S., Challis, R. & Fisher, F. (2004) Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR. Clinical and Laboratory Haematology, 26, 4347.
  • Kearon, C., Ginsberg, J.S., Kovacs, M.J., Anderson, D.R., Wells, P., Julian, J.A., MacKinnon, B., Weitz, J.I., Crowther, M.A., Dolan, S., Turpie, A.G., Geerts, W., Solymoss, S., van Nguyen, P., Demers, C., Kahn, S.R., Kassis, J., Rodger, M., Hambleton, J. & Gent, M. (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. New England Journal of Medicine, 349, 631639.
  • Kearon, C., Ginsberg, J.S., Anderson, D.R., Kovacs, M.J., Wells, P., Julian, J.A., Mackinnon, B., Demers, C., Douketis, J., Turpie, A.G., Van Nguyen, P., Green, D., Kassis, J., Kahn, S.R., Solymoss, S., Desjardins, L., Geerts, W., Johnston, M., Weitz, J.I., Hirsh, J. & Gent, M. (2004) Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis, 2, 743749.
  • Kovacs, M.J., Rodger, M., Anderson, D.R., Morrow, B., Kells, G., Kovacs, J., Boyle, E. & Wells, P.S. (2003) Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Annals of Internal Medicine, 138, 714719.
  • Landefield, C. & Beyth, R. (1993) Anticoagulant related bleeding: clinical epidemiology, prediction and prevention. American Journal of Medicine, 95, 315328.
  • Lee, A.Y., Levine, M.N., Baker, R.I., Bowden, C., Kakkar, A.K., Prins, M., Rickles, F.R., Julian, J.A., Haley, S., Kovacs, M.J. & Gent, M. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New England Journal of Medicine, 349, 146153.
  • Lee, A.Y., Rickles, F.R., Julian, J.A., Gent, M., Baker, R.I., Bowden, C., Kakkar, A.K., Prins, M. & Levine, M.N. (2005) Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. Journal of Clinical Oncology, 23, 21232129.
  • Mackenzie, A.R., Laing, R.B., Douglas, J.G., Greaves, M. & Smith, C.C. (2000) High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgraduate Medical Journal, 76, 561565.
  • Makris, M., Greaves, M., Phillips, W.S., Kitchen, S., Rosendaal, F.R. & Preston, E.F. (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis, 77, 477480.
  • Marietta, M., Bertesi, M., Simoni, L., Pozzi, S., Castelli, I., Cappi, C. & Torelli, G. (2003) A simple and safe nomogram for the management of oral anticoagulation prior to minor surgery. Clinical and Laboratory Haematology, 25, 127130.
  • Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J.M., Cottu, P. & Farge, D. (2002) Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Archives of Internal Medicine, 162, 17291735.
  • Michaels, L. & Beamish, R.E. (1967) Relapses of thromboembolic disease after discontinued anticoagulant therapy. A comparison of the incidence after abrupt and after gradual termination of treatment. American Journal of Cardiology, 20, 670673.
  • Murray, E.T., Fitzmaurice, D.A. & McCahon, D. (2004) Point of care testing for INR monitoring: where are we now? British Journal of Haematology, 127, 373378.
  • Oates, A., Jackson, P.R., Austin, C.A. & Channer, K.S. (1998) A new regimen for starting warfarin therapy in out-patients. British Journal of Clinical Pharmacology, 46, 157161.
  • Olshansky, B. (2002) High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truth. Journal of the American College of Cardiology, 40, 934936.
  • Palareti, G. & Coccheri, S. (1996) Rebound hypercoagulability after discontinuation of oral anticoagulants. In: Oral Anticoagulants (ed. by L.Poller & J.Hirsh), pp. 264272. Arnold, London.
  • Palareti, G., Legnani, C., Guazzaloca, G., Frascaro, M., Grauso, F., De Rosa, F., Fortunato, G. & Coccheri, S. (1994) Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants – a prospective study. Thrombosis and Haemostasis, 72, 222226.
  • Pinede, L., Duhaut, P., Cucherat, M., Ninet, J., Pasquier, J. & Boissel, J.P. (2000) Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials. Journal of Internal Medicine, 247, 553562.
  • Pinede, L., Ninet, J., Duhaut, P., Chabaud, S., Demolombe-Rague, S., Durieu, I., Nony, P., Sanson, C. & Boissel, J.P. (2001) Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation, 103, 24532460.
  • Ridker, P.M. (2004) Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes. Journal of Thrombosis and Haemostasis, 2, 10341037.
  • Ridker, P.M., Goldhaber, S.Z., Danielson, E., Rosenberg, Y., Eby, C.S., Deitcher, S.R., Cushman, M., Moll, S., Kessler, C.M., Elliott, C.G., Paulson, R., Wong, T., Bauer, K.A., Schwartz, B.A., Miletich, J.P., Bounameaux, H. & Glynn, R.J. (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine, 348, 14251434.
  • Rosendaal, F., Cannegieter, S., van der Meer, F. & Briet, E. (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69, 236239.
  • Rothberg, M.B., Celestin, C., Fiore, L.D., Lawler, E. & Cook, J.R. (2005) Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Annals of Internal Medicine, 143, 241250.
  • Salem, D.N., Stein, P.D., Al-Ahmad, A., Bussey, H.I., Horstkotte, D., Miller, N. & Pauker, S.G. (2004) Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 457S482S.
  • Sarac, T.P., Huber, T.S., Back, M.R., Ozaki, C.K., Carlton, L.M., Flynn, T.C. & Seeger, J.M. (1998) Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. Journal of Vascular Surgery, 28, 446457.
  • Tait, R.C. & Sefcick, A. (1998) A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation. British Journal of Haematology, 101, 450454.
  • Tinker, J.H. & Tarhan, S. (1978) Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. Journal of the American Medical Association, 239, 738739.
  • Van Cleve, R. (1965) The rebound phenomenon-fact or fancy? Experience with discontinuation of long-term anticoagulation therapy after myocardial infarction. Circulation, 32, 878880.
  • Watson, H.G., Baglin, T., Laidlaw, S.L., Makris, M. & Preston, F.E. (2001) A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin. British Journal of Haematology, 115, 145149.
  • Yasaka, M., Sakata, T., Minematsu, K. & Naritomi, H. (2002) Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thrombosis Research, 108, 2530.
  • Yasaka, M., Minematsu, K., Naritomi, H., Sakata, T. & Yamaguchi, T. (2003) Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thrombosis and Haemostasis, 89, 278283.